Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Bitcoin Heads Towards $30,000 As It Hits New Peak Despite Ongoing Market Woes
-
World Markets At This Hour
-
Zymeworks Up 10% On Positive Study Results Of Zanidatamab In Biliary Tract Cancer Treatment
-
The DRC-20 Effect: How Dogecoin Tokens Outpaced Bitcoin’s Daily Transactions
-
Cryptos Firm Amidst FOMC Minutes, Economic Data
